About Conference PULSUS GROUP takes pleasure in extending our welcome to invite all participants from a global reach to attend “8th International Conference on Neurodegenerative Disorders & Stroke” scheduled from December 04th to December 05th , 2019 at Prague, Czech Republic, which will entail lively debates, prompt keynote presentations, Oral talks, poster presentations, workshops and networking opportunities around a core of plenary and concurrent sessions based on pivotal issues in the sector. This is a grandeur summit involving healthcare professionals, academicians, students, and researchers worldwide. Stroke-2019 is our 8th latest addition to our conferences in the field of neurodegenerative disorders and stroke. We focus on recognizing the people in the field who are doing astounding research in neurodegenerative disorders and stroke that would be beneficial for all the aspects of neurology. neuroscience, neurodegenerative doisorders, and neurosurgery and has the ability to revolutionize the field in the future. On behalf of the Stroke 2019 committee, we are pleased to invite you to join the upcoming “9th International Conference on Neurodegenerative Disorders and Stroke” to be held during December 04-05, 2019 in Dubai, UAE, where you can explore the who is who of the field, find an astounding network to create exemplary outcomes. Target Audience Neurologists

Neurosurgeons

Doctors / Physicians

Scientists and Professors

Neuro Research scholars

Medical Universities

Research faculty

Pharmaceutical industries

Academic Scientists

Students

Diagnostic laboratory professionals

Medical Device and Pharmaceutical Entrepreneurs

Medical Industry professionals

Brand Manufacturers/ Marketers of Consumer Products

Marketing, Advertising and Promotion Agency Executives

Market Analysis Over a billion people (13.46% of the global population) are affected by neurological disorders, 350 million people are suffering from heavy depression globally with a high concentration in certain Asian countries like South Korea, Japan, and China. 50 million brain aneurysm related deaths every year with half aged below 50, The global market in this field is expected to grow by 36.7 bn (7.4% CAGR), US Stroke management market - 48.984 bn by 2023 Neuro therapeutics CAGR - 13.5% (2017-23) FROM $27.Bn to $45Bn. 10% of the deaths every year globally are due to neurological disorders. 5.4 Mn in the US are living with Alzheimer's, Global Neuromarketing is expected to have a CAGR of 12%. The EU incurs the cost of US$51.4 Bn annually due to stroke apart from human capital loss in the Economy. The global neuropathic pain market growth shows a CAGR of 6.06% due to an uptick in Diabetes and Cancer cases. The demand for novel treatment methods is going to spur in the market! North America is the largest supplier of the Neurofeedback system, with a production market share of around 20.05%. Considering the ever-increasing industrialization and stress levels in developing countries like India, Indonesia and emerging markets of Africa, there is a strong growing demand and a high level of proper treatment in demand at these regions. In India, the Diagnostics sector dominates the Market and India would continue to be a dominant market till 2022 achieving a market value of $1.8 Billion. With an excessive demand and need globally, the conference invites people to create change share knowledge, inspire others with their exceptional work and make the world a better place!